Citation: T. Buchner et al., IMPLANTATION OF INTRAOCULAR LENSES IN CHI LDREN - FUNCTIONAL RESULTS AND COMPLICATIONS, Der Ophthalmologe, 95(5), 1998, pp. 307-316
Authors:
KERN W
AUL C
MASCHMEYER G
KUSE R
KERKHOFF A
GROTEMETKE A
EIMERMACHER H
KUBICA U
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., GRANULOCYTE-COLONY-STIMULATING FACTOR SHORTENS DURATION OF CRITICAL NEUTROPENIA AND PROLONGS DISEASE-FREE SURVIVAL AFTER SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (S-HAM) SALVAGE THERAPY FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA, Annals of hematology, 77(3), 1998, pp. 115-122
Authors:
KERN W
AUL C
MASCHMEYER G
SCHONROCKNABULSI R
LUDWIG WD
BARTHOLOMAUS A
BETTELHEIM P
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., SUPERIORITY OF HIGH-DOSE OVER INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED PROSPECTIVE RANDOMIZED COMPARISON, Leukemia, 12(7), 1998, pp. 1049-1055
Authors:
SCHUMACHER A
KESSLER T
BUCHNER T
WEWERS D
VANDELOO J
Citation: A. Schumacher et al., QUALITY-OF-LIFE IN ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA RECEIVING INTENSIVE AND PROLONGED CHEMOTHERAPY - A LONGITUDINAL-STUDY, Leukemia, 12(4), 1998, pp. 586-592
Authors:
KERN W
BRAESS J
GROTEMETKE A
KUSE H
FUCHS R
HOSSFELD DK
REICHLE A
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., COMBINATION OF ACLARUBICIN AND ETOPOSIDE FOR THE TREATMENT OF ADVANCED ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE MULTICENTER PHASE-II TRIAL, Leukemia, 12(10), 1998, pp. 1522-1526
Authors:
FREUND M
HEIL G
ARNOLD R
BALLEISEN L
BUCHNER T
DIEDRICH H
EIMERMACHER H
FONATSCH C
GANSER A
GASSMANN W
HARTMANN F
HIDDEMANN W
KASPER C
KNAUF WU
KOCH P
KUBICA U
LINK H
LOFFLER H
LUDWIG WD
MASCHMEYER G
POMPE K
SCHADECK C
SCHMITZ N
SCHONROCKNABULSI P
SCHWONZEN M
THIEL E
WEISS A
HOELZER D
Citation: M. Freund et al., THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 22, 1998, pp. 10-10
Authors:
KERN W
BEHRE G
RUDOLF T
KERKHOFF A
GROTEMETKE A
EIMERMACHER H
KUBICA U
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., FAILURE OF FLUCONAZOLE PROPHYLAXIS TO REDUCE MORTALITY OR THE REQUIREMENT OF SYSTEMIC AMPHOTERICIN-B THERAPY DURING TREATMENT FOR REFRACTORY ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE RANDOMIZED PHASE-III STUDY, Cancer, 83(2), 1998, pp. 291-301
Authors:
SCHNITTGER S
STICHWEH S
KINKELIN U
SCHOCH C
HAASE D
WORMANN B
BUCHNER T
LOFFLER H
HAFERLACH T
HIDDEMANN W
Citation: S. Schnittger et al., AML1-ETO FUSION TRANSCRIPTS ARE SPECIFICALLY ASSOCIATED WITH T(8-21)(Q22-Q22) AND AML M1 AND M2, British Journal of Haematology, 102(1), 1998, pp. 32-32
Authors:
SCHOCH C
KLAUS M
HAASE D
WORMANN B
BUCHNER T
HAFERLACH T
HIDDEMANN W
Citation: C. Schoch et al., THE DELETION OF CRITICAL REGIONS ON CHROMOSOME-5, CHROMOSOME-7 AND CHROMOSOME-17 IN PATIENTS WITH AML AND COMPLEX KARYOTYPE SEEM TO BE MOREIMPORTANT THAN REARRANGEMENTS OF SPECIFIC GENES - A FLUORESCENCE IN-SITU HYBRIDIZATION STUDY ON 30 CASES, British Journal of Haematology, 102(1), 1998, pp. 101-101
Authors:
SPAHN G
SPERLING C
BUCHNER T
CREUTZIG U
SCHLEGELBERGER B
HARBOTT J
DOHNER H
DORKEN B
LUDWIG WD
Citation: G. Spahn et al., 5 CHILDREN AND 7 ADULTS WITH CD7- ACUTE NATURAL-KILLER-CELL LEUKEMIA(CD56+ CD3), British Journal of Haematology, 102(1), 1998, pp. 114-114
Authors:
STREUBEL B
SAUERLAND C
HEIL G
FREUND M
BARTELS H
LENGFELDER E
WANDT H
LUDWIG WD
NOWOTNY H
BALDUS M
GROTHAUSPINKE B
BUCHNER T
FONATSCH C
Citation: B. Streubel et al., CORRELATION OF CYTOGENETIC, MOLECULAR CYTOGENETIC, AND CLINICAL FINDINGS IN 59 PATIENTS WITH ANLL OR MDS AND ABNORMALITIES OF THE SHORT ARMOF CHROMOSOME-12, British Journal of Haematology, 100(3), 1998, pp. 521-533
Authors:
KRATZALBERS K
ZUHLSDORF M
LEO R
BERDEL WE
BUCHNER T
SERVE H
Citation: K. Kratzalbers et al., EXPRESSION OF AC133, A NOVEL STEM-CELL MARKER, ON HUMAN LEUKEMIC BLASTS LACKING CD34(-) ANTIGEN AND ON A HUMAN CD34(-CELL LINE - MUTZ-2() LEUKEMIC), Blood, 92(11), 1998, pp. 4485-4487
Authors:
DREYLING MH
SCHRADER K
FONATSCH C
SCHLEGELBERGER B
HAASE D
SCHOCH C
LUDWIG WD
LOFFLER H
BUCHNER T
WORMANN B
HIDDEMANN W
BOHLANDER SK
Citation: Mh. Dreyling et al., MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DISTINCT SUBSETS OFACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS ARE ASSOCIATED WITH A POOR-PROGNOSIS, Blood, 91(12), 1998, pp. 4662-4667
Authors:
EDWARDS JE
BODEY GP
BOWDEN RA
BUCHNER T
DEPAUW BE
FILLER SG
GHANNOUM MA
GLAUSER M
HERBRECHT R
KAUFFMAN CA
KOHNO S
MARTINO P
MEUNIER F
MORI T
PFALLER MA
REX JH
ROGERS TR
RUBIN RH
SOLOMKIN J
VISCOLI C
WALSH TJ
WHITE M
Citation: Je. Edwards et al., INTERNATIONAL-CONFERENCE FOR THE DEVELOPMENT OF A CONSENSUS ON THE MANAGEMENT AND PREVENTION OF SEVERE CANDIDAL INFECTIONS, Clinical infectious diseases, 25(1), 1997, pp. 43-59
Authors:
HIDDEMANN W
JAHNSSTREUBEL G
HAASE D
SCHOCH C
FONATSCH C
WORMANN B
BUCHNER T
Citation: W. Hiddemann et al., HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF ACUTE LEUKEMIAS THE DEVELOPMENT OF BIOLOGICALLY DEFINED CONCEPTS, European journal of cancer, 33, 1997, pp. 11-11
Authors:
VERBEEK W
WORMANN B
KOCH P
AUL C
HINRICHS H
BALLEISEN L
ROWE JM
BENNETT J
BUCHNER T
HIDDEMANN W
Citation: W. Verbeek et al., S-HAM INDUCTION CHEMOTHERAPY WITH OR WITHOUT GM-CSF IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES, Annals of hematology, 74(5), 1997, pp. 205-208
Citation: M. Zuhlsdorf et al., DECREASE IN ARTERIAL OXYGEN PARTIAL-PRESSURE WITHIN THE FIRST 24 H OFRHGM-CSF ADMINISTRATION IN AML PATIENTS, European journal of haematology, 59(5), 1997, pp. 293-298
Authors:
REUTER C
SCHLEYER E
ROLF C
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: C. Reuter et al., DIFFERENTIAL EFFECT OF GM-CSF PRETREATMENT ON INTRACELLULAR ARA-C METABOLISM IN NORMAL BONE-MARROW MONONUCLEAR-CELLS VS ACUTE MYELOID-LEUKEMIA (AML) BLASTS, Leukemia, 11(4), 1997, pp. 561-571
Authors:
BUCHNER T
HIDDEMANN W
WORMANN B
ZUHLSDORF M
ROTTMANN R
INNIG G
MASCHMEIER G
LUDWIG WD
SAUERLAND MC
HEINECKE A
Citation: T. Buchner et al., HEMATOPOIETIC GROWTH-FACTORS IN ACUTE MYELOID-LEUKEMIA - SUPPORTIVE AND PRIMING EFFECTS, Seminars in oncology, 24(1), 1997, pp. 124-131
Authors:
KERN W
SCHLEYER E
UNTERHALT M
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., HIGH ANTILEUKEMIC ACTIVITY OF SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE IN PATIENTS WITH REFRACTORY ACUTE LEUKEMIAS - RESULTS OF A CLINICAL-PHASE-II STUDY, Cancer, 79(1), 1997, pp. 59-68